{"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"groups":[{"description":"Single intravenous administration of rhPSMA-7.3 (18F) for PET Scan\n\nrhPSMA-7.3 (18F) Injection: Radioligand for PET CT scanning\n\nPositron emission tomography scan: Imaging scan with radioligand","id":"BG000","title":"Single Arm"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"121"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"270"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"7.92","value":"68.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"391"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"18"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"342"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"31"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"61"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"295"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Not Reported"}],"description":"Race split into 3 substantive categories and also those for whom it was not reported","paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"375"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Finland"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"39"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"≤6"},{"categories":[{"measurements":[{"groupId":"BG000","value":"232"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=7"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=8"},{"categories":[{"measurements":[{"groupId":"BG000","value":"63"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=9"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=10"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Missing"}],"description":"Gleason score (defined by the International Society of Urological Pathologists) was based on prostate biopsy.\n\nScore 6 - The cells look similar to normal prostate cells. The cancer is likely to grow very slowly, if at all\n\nScore 7 - Most cells still look similar to normal prostate cells. The cancer is likely to grow slowly\n\nScore 8 - Some cells look abnormal. The cancer might grow quickly or at a moderate rate\n\nScore 9 or 10 - The cells look very abnormal. The cancer is likely to grow quickly","paramType":"NUMBER","title":"Total Gleason Score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"39"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"104"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"116"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=4"},{"categories":[{"measurements":[{"groupId":"BG000","value":"64"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"=5"},{"categories":[{"measurements":[{"groupId":"BG000","value":"27"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Missing"}],"description":"GGG (defined by the International Society of Urological Pathologists) was based on prostate biopsy.\n\nGroup 1: The cells look similar to normal prostate cells. The cancer is likely to grow very slowly, if at all\n\nGroup 2: Most cells still look similar to normal prostate cells. The cancer is likely to grow slowly\n\nGroup 3: The cells look less like normal prostate cells. The cancer is likely to grow at a moderate rate\n\nGroup 4: Some cells look abnormal. The cancer might grow quickly or at a moderate rate\n\nGroup 5: The cells look very abnormal. The cancer is likely to grow quickly","paramType":"NUMBER","title":"Gleason Grade Group (GGG)","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"54"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T1c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"52"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T2a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T2b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"63"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T2c"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"82"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T3a"},{"categories":[{"measurements":[{"groupId":"BG000","value":"68"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T3b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"T4"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"TX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Missing"}],"description":"Pathological TNM stage was used if available, otherwise the clinical TNM was used.\n\nT1 means the cancer is too small to be seen on a scan, or felt during an examination of the prostate T1a means that the cancer is in less than 5% of the removed tissue T1c cancers are found by biopsy T2 means the cancer is completely inside the prostate gland T3a means the cancer has broken through the capsule (covering) of the prostate gland T3b means the cancer has spread into the tubes that carry semen (seminal vesicles) T4 means the cancer has spread into other body organs nearby","paramType":"NUMBER","title":"TNM (Tumor-Node-Metastasis) Stage T","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"249"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"N0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"53"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"N1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"61"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"NX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"28"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Missing"}],"description":"Pathological TNM stage was used if available, otherwise the clinical TNM was used.\n\nN0 means that the nearby lymph nodes don't contain cancer cells\n\nN1 means there are cancer cells in lymph nodes near the prostate","paramType":"NUMBER","title":"TNM Stage N","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"243"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"M0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"M1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"M1b"},{"categories":[{"measurements":[{"groupId":"BG000","value":"106"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"MX"},{"categories":[{"measurements":[{"groupId":"BG000","value":"40"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"391"}],"units":"Participants"}],"title":"Missing"}],"description":"Pathological TNM stage was used if available, otherwise the clinical TNM was used.\n\nM0 means the cancer hasn't spread to other parts of your body.\n\nM1 means the cancer has spread to other parts of the body outside the pelvis. It is split into M1a, M1b and M1c.\n\nM1a means there are cancer cells in lymph nodes outside the pelvis\n\nM1b means there are cancer cells in the bone\n\nM1c means there are cancer cells in other parts of the body such as the lungs","paramType":"NUMBER","title":"TNM Stage M","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"4.740","value":"28.68"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"334"}],"units":"Participants"}]}],"description":"BMI was calculated as weight in kg divided by height in m2.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Not all subjects had height and weight measured (eg only 337 subjects had height at baseline) - the trial was conducted during the Covid pandemic.","title":"Body Mass Index (BMI)","unitOfMeasure":"Kg/m2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"65.70","value":"87.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"389"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Date of cancer diagnosis was not available for 2 participants.","title":"Time since initial cancer diagnosis","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"27.15","value":"17.1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"390"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Date of diagnosis of biochemical recurrence not available for all participants","title":"Time since diagnosis of biochemical recurrence","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"50.26","value":"67.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"190"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Not all participants had adjuvant treatment and start date not always available for all participants who had adjuvant treatment.","title":"Time since start of adjuvant treatment","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"49.11","value":"60.2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"192"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Not all participants had adjuvant treatment and end date not always available for all participants who had adjuvant treatment.","title":"Time since end of adjuvant treatment","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"16.05","value":"7.2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"187"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Not all participants had adjuvant treatment and start and end dates not always available for all participants who had adjuvant treatment in order to calculate duration.","title":"Duration of adjuvant treatment","unitOfMeasure":"months"}],"populationDescription":"All patients who were scheduled to receive the rhPSMA-7.3 (18F) injection having met the inclusion/exclusion criteria or who received the rhPSMA-7.3 (18F) injection."}